Literature DB >> 3754562

Primary hyperparathyroidism with low serum 1,25-dihydroxyvitamin D levels.

J Wortsman, J G Haddad, J T Posillico, E M Brown.   

Abstract

Primary hyperparathyroidism is usually associated with normal or elevated serum 1,25-dihydroxyvitamin D [1,25-(OH)2D] levels. We report a patient with extreme hypercalcemia (serum calcium, 19.4 mg/dl), primary hyperparathyroidism, and a very low plasma concentration of 1,25-(OH)2D. Surgical removal of a large parathyroid adenoma was associated with a decrease in the serum calcium and immuno- and bioactive PTH concentrations and normalization of the 1,25-(OH)2D level. The postoperative course was complicated by severe protracted hypocalcemia and cardiac arrest, requiring treatment with large doses of calcium iv. The low concentrations of 1,25-(OH)2D in this patient are an unusual manifestation of primary hyperparathyroidism, probably due to suppression of renal 1 alpha-hydroxylase activity by the severe hypercalcemia. We conclude that in severe hypercalcemia, a low serum 1,25-(OH)2D level does not exclude the diagnosis of primary hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3754562     DOI: 10.1210/jcem-62-6-1305

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  2 in total

1.  The effect of vitamin D status on the severity of bone disease and on the other features of primary hyperparathyroidism (pHPT) in a vitamin D deficient region.

Authors:  H Raef; S Ingemansson; S Sobhi; A Sultan; M Ahmed; M Chaudhry
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

2.  1alpha,25-dihydroxyvitamin D3 acts predominately in mature osteoblasts under conditions of high extracellular phosphate to increase fibroblast growth factor 23 production in vitro.

Authors:  Ryoko Yamamoto; Tomoko Minamizaki; Yuji Yoshiko; Hirotaka Yoshioka; Kazuo Tanne; Jane E Aubin; Norihiko Maeda
Journal:  J Endocrinol       Date:  2010-06-08       Impact factor: 4.286

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.